Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alkylresorcinol extract is a concentrated preparation containing **alkylresorcinols (ARs)**, a family of bioactive phenolic lipids found in significant amounts in the bran fractions of cereals, especially wheat and rye[1][3][4]. ARs have a lipophilic polyphenolic structure and vary by side-chain length and functional groups (saturated, unsaturated, and oxo-functionalized). Extracts are typically obtained using methods such as ultrasound-assisted extraction, Soxhlet extraction with acetone, or solvent-assisted maceration, each yielding different profiles of AR homologs[1]. Bioactivity studies demonstrate that these extracts, particularly those enriched in oxidized AR homologs, exhibit **antiproliferative effects against prostate cancer cell lines (PC-3)**, with activity depending on molecular structure and extraction method[1]. The mechanism of action has not been fully characterized, but ARs are considered to interact with cellular membranes and regulate oxidative stress and cellular proliferation[3]. Alkylresorcinol extract is primarily researched as a functional ingredient for foods, nutraceuticals, and dietary supplements.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alkylresorcinol extract.